Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP

Cell Death and Differentiation

Volumn 18, Issue 3, 2011, Pages 396-404

  Casati, A ^a,b   Frascoli, M ^a   Traggiai, E ^c   Proietti, M ^a   Schenk, U ^a   Grassi, F ^a,b  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b UNIVERSITY OF MILAN   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

ATP; cell cycle; hematopoietic stem cell; inflammation; purinergic receptors

Indexed keywords

ADENOSINE TRIPHOSPHATE; PERIODATE OXIDIZED 2,3 DIALDEHYDE ADENOSINE TRIPHOSPHATE; PURINERGIC P2X RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; CELL AUTONOMOUS REGULATION; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHRONIC INFLAMMATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; INTRACELLULAR MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC DISEASE; CYTOPLASMIC VESICLES; HEMATOPOIETIC STEM CELLS; INFLAMMATION; MICE; MYELOID CELLS; PURINERGIC P2X RECEPTOR ANTAGONISTS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

MUS;

EID: 79951676433     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.107     Document Type: Article

References (46)

1. Weissman IL. Stem cells: units of development, units of regeneration, (Pubitemid 30046304)
2. Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006; 24: 801-812. (Pubitemid 43867369)
3. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009; 458: 904-908.
4. Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 2009; 15: 696-700.
5. Wilson A, Laurenti E, Oser G, Van der Wath RC, Blanco-Bose W, Jaworski M et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008; 135: 1118-1129.
6. Corriden R, Insel PA. Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci Signal 2010; 3: re1.
7. Burnstock G. Purinergic signaling - an overview. Novartis Found Symp 2006; 276: 26-48; discussion 48-57, 275-281.
8. Lemoli RM, Ferrari D, Fogli M, Rossi L, Pizzirani C, Forchap S et al. Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood 2004; 104: 1662-1670. (Pubitemid 39202272)
9. Surprenant A, North RA. Signaling at purinergic P2X receptors. Annu Rev Physiol 2008; 71: 333-359.
10. Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, Rosa P et al. Storage and release of ATP from astrocytes in culture. J Biol Chem 2003; 278: 1354-1362. (Pubitemid 36790821)
11. Locovei S, Bao L, Dahl G. Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci USA 2006; 103: 7655-7659.
12. Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci 2008; 28: 4702-4711.
13. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273: 242-245. (Pubitemid 26285891)
14. Corriden R, Insel PA, Junger WG. A novel method using fluorescence microscopy for real-time assessment of ATP release from individual cells. Am J Physiol Cell Physiol 2007; 293: C1420-C1425. (Pubitemid 47556749)
15. Bodin P, Burnstock G. ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol 1996; 27: 872-875. (Pubitemid 26170845)
16. Clark AK, Staniland AA, Marchand F, Kaan TK, McMahon SB, Malcangio M. P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. J Neurosci 2010; 30: 573-582.
17. Kalvegren H, Skoglund C, Helldahl C, Lerm M, Grenegard M, Bengtsson T. Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation. Thromb Haemost 2010; 103: 398-407.
18. Murgia M, Hanau S, Pizzo P, Rippa M, Di Virgilio F. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J Biol Chem 1993; 268: 8199-8203. (Pubitemid 23120407)
19. Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol Pharmacol 1995; 48: 178-183.
20. Jacques-Silva MC, Correa-Medina M, Cabrera O, Rodriguez-Diaz R, Makeeva N, Fachado A et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc Natl Acad Sci USA 2010; 107: 6465-6470.
21. Rettinger J, Braun K, Hochmann H, Kassack MU, Ullmann H, Nickel P et al. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist. Neuropharmacology 2005; 48: 461-468. (Pubitemid 40250009)
22. Donnelly-Roberts D, McGaraughty S, Shieh CC, Honore P, Jarvis MF. Painful purinergic receptors. J Pharmacol Exp Ther 2008; 324: 409-415. (Pubitemid 351185825)
23. Porcellini S, Traggiai E, Schenk U, Ferrera D, Matteoli M, Lanzavecchia A et al. Regulation of peripheral T cell activation by calreticulin. J Exp Med 2006; 203: 461-471. (Pubitemid 43290854)
24. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-533. (Pubitemid 37328672)
25. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170: 3939-3943. (Pubitemid 36428153)
26. Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 2005; 201: 1771-1780. (Pubitemid 41002896)
27. Hirai H, Zhang P, Dayaram T, Hetherington CJ, Mizuno S, Imanishi J et al. C/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol 2006; 7: 732-739.
28. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997; 91: 661-672. (Pubitemid 27513657)
29. Zhang P, Nelson S, Bagby GJ, Siggins II R, Shellito JE, Welsh DA. The lineage-c-Kit+Sca-1+ cell response to Escherichia coli bacteremia in Balb/c mice. Stem Cells 2008; 26: 1778-1786.
30. Bowie MB, McKnight KD, Kent DG, McCaffrey L, Hoodless PA, Eaves CJ. Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J Clin Invest 2006; 116: 2808-2816. (Pubitemid 44511644)
31. Yamazaki S, Iwama A, Takayanagi S, Morita Y, Eto K, Ema H et al. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 2006; 25: 3515-3523. (Pubitemid 44264862)
32. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111. (Pubitemid 33041634)
33. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-161. (Pubitemid 38962572)
34. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-846. (Pubitemid 37351468)
35. Yamazaki S, Iwama A, Takayanagi S, Eto K, Ema H, Nakauchi H. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood 2009; 113: 1250-1256.
36. Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001; 193: 1005-1014. (Pubitemid 32436194)
37. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-841. (Pubitemid 37351467)
38. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121: 1109-1121. (Pubitemid 40884400)
39. Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004; 103: 3258-3264. (Pubitemid 38525648)
40. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004; 10: 64-71. (Pubitemid 38524700)
41. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 2005; 20: 349-356. (Pubitemid 41457400)
42. Arai F, Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007; 1106: 41-53. (Pubitemid 47443041)
43. Bodin P, Bailey D, Burnstock G. Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol 1991; 103: 1203-1205.
44. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, Stenmark KR. Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem 2002; 277: 44638-44650. (Pubitemid 36159053)
45. Sedaa KO, Bjur RA, Shinozuka K, Westfall DP. Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. J Pharmacol Exp Ther 1990; 252: 1060-1067. (Pubitemid 20127410)
46. Adamo L, Naveiras O, Wenzel PL, McKinney-Freeman S, Mack PJ, Gracia-Sancho J et al. Biomechanical forces promote embryonic haematopoiesis. Nature 2009; 459: 1131-1135.